ARTHREX INC.

Company Snapshot

Founded: 1981
Entity Type: Private
Region: U.S.
Headquarter: Florida, U.S.
Key Geographics: North America, Asia-Pacific, Rest of World, Europe, Middle East and Africa
Corporate Address: 1370 Creekside Blvd. Naples, Florida 34108 U.S. Tel: +1-800-934-4404 www.arthrex.com

Company Overview

Arthrex Inc. is a privately held global medical device company that offers orthopedic products. Arthrex, Inc. was formerly known as Arthroscopy Excision Instruments Inc. The company was founded in 1981 and is headquartered in Naples, Florida. The company offers products for shoulder, knee, elbow, hand & wrist, foot & ankle, and hip conditions. In addition, the company is also engaged in providing orthobiologics for autologous blood products, bone grafting, cartilage, cellular products, soft tissue, and wound care. The company has worldwide presence in São Paulo, Brazil; Walnut and Santa Barbara, California; Sheffield, United Kingdom; Wiener Neudorf, Austria; Naples, Florida; Zagreb, Croatia; Munich, Germany; Kontich, Belgium; Copenhagen, Denmark; Høvik, Norway; México D.F., Mexico; Madrid, Spain; Tokyo, Japan; Seoul, Korea; Lezennes, France; Son en Breugel, the Netherlands; Belp-Bern, Switzerland; Warsaw, Poland; Shanghai, China; Stockholm, Sweden; and Dubai, United Arab Emirates.

ARTHREX INC. In Reports

Advanced Orthopedic Technologies, Implants and Regenerative Products

According to BCC Research Report global market for advanced orthopedic market is estimated to increase from $66.4 billion in 2023 to reach $84.8 billion by 2028.

Regenerative Medicines: Bone and Joint Applications

BCC Research Market Report says global market for regenerative medicine in bone and joint applications reached $9.6 billion in 2022 and estimated to increase from $10.7 billion in 2023 to $18.9 billion by 2028.

Regenerative Medicines: Bone and Joint Applications

BCC Research Market Report for Regenerative Medicines specific to Bone and Joint Applications. Regenerative Medicines market size and analyses of global market trends, with CAGRs through 2026.

Company's Business Segments

  • Product : Bone Preparation, Cannulas, Fracture Management, Hand Instruments, Knee Fracture Management, Fixation Devices, Knee Hand Instruments, Knee Ligament Reconstruction Instruments, Cannulas, Elbow Limb Positioner, Instrument Sets, Soft Tissue Fixation Devices, Arthroplasty Shoulder, Arthroscopy, Carpal Tunnel Syndrome, Fixation System, Fracture and Fusion Devices, Arthroscopic Instrumentation, Endoscopic Soft-Tissue Release, Fixation System, Limb Positioners, Core Decompression, Disposable Instruments, Bone, Cellular Products, Sternal Closure Systems, Biologics, Imaging, Soft Tissue Closure, Fusion Support.

Applications/End User Industries

  • Healthcare
  • Orthopedics
  • Medical Devices
  • Sports Medicine